Glioblastoma, renal clear cell (RCC) carcinoma and ovarian carcinoma exhibited approximately normal levels of HSP90 transcripts, whereas acute myeloid leukemia (AML) had lower gene expression of HSP90. This evidence concerns the gene HSP90AA1 and carcinoma.